Ocuphire Pharma, Inc.
OCUPDrugs in Pipeline
9
Phase 3 Programs
5
Upcoming Catalysts
1
Next Catalyst
Aug 2027
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist
Mesopic Vision
Phentolamine Opthalmic Solution 0.75%
Presbyopia
0.75% phentolamine ophthalmic solution
Presbyopia
Phentolamine Ophthalmic Solution Vehicle
Mydriasis
Phentolamine Ophthalmic Solution 0.75%
Mydriasis
Phentolamine Mesylate Ophthalmic Solution 1%
Open Angle Glaucoma
Pilocarpine
Presbyopia
APX3330
Diabetic Retinopathy
Phentolamine Mesylate Ophthalmic Solution 1.0%
Night Vision Complaints
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist | Phase 3 | Mesopic Vision | - | - |
Phentolamine Opthalmic Solution 0.75% | Phase 3 | Presbyopia | - | - |
0.75% phentolamine ophthalmic solution | Phase 3 | Presbyopia | - | - |
Phentolamine Ophthalmic Solution Vehicle | Phase 3 | Mydriasis | - | - |
Phentolamine Ophthalmic Solution 0.75% | Phase 3 | Mydriasis | - | - |
Phentolamine Mesylate Ophthalmic Solution 1% | Phase 2 | Open Angle Glaucoma | - | - |
Pilocarpine | Phase 2 | Presbyopia | - | - |
APX3330 | Phase 2 | Diabetic Retinopathy | - | - |
Phentolamine Mesylate Ophthalmic Solution 1.0% | Phase 2 | Night Vision Complaints | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Ocuphire Pharma, Inc.'s drug pipeline?→
CatalystAlert tracks 9 drug candidates in Ocuphire Pharma, Inc.'s (OCUP) pipeline across Phase 3, Phase 2. Its lead program is phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Ocuphire Pharma, Inc.'s next FDA catalyst?→
Ocuphire Pharma, Inc.'s (OCUP) next tracked catalyst is a Phase 3 expected August 15, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track OCUP biotech catalysts?→
Add OCUP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Ocuphire Pharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.